155 related articles for article (PubMed ID: 34503219)
1. Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer.
Kilmartin D; O'Loughlin M; Andreu X; Bagó-Horváth Z; Bianchi S; Chmielik E; Cserni G; Figueiredo P; Floris G; Foschini MP; Kovács A; Heikkilä P; Kulka J; Laenkholm AV; Liepniece-Karele I; Marchiò C; Provenzano E; Regitnig P; Reiner A; Ryška A; Sapino A; Specht Stovgaard E; Quinn C; Zolota V; Webber M; Roshan D; Glynn SA; Callagy G
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503219
[TBL] [Abstract][Full Text] [Related]
2. Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study.
O'Loughlin M; Andreu X; Bianchi S; Chemielik E; Cordoba A; Cserni G; Figueiredo P; Floris G; Foschini MP; Heikkilä P; Kulka J; Liepniece-Karele I; Regitnig P; Reiner A; Ryska A; Sapino A; Shalaby A; Stovgaard ES; Quinn C; Walsh EM; Zolota V; Glynn SA; Callagy G
Breast Cancer Res Treat; 2018 Aug; 171(1):1-9. PubMed ID: 29774470
[TBL] [Abstract][Full Text] [Related]
3. Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study.
Van Bockstal MR; François A; Altinay S; Arnould L; Balkenhol M; Broeckx G; Burguès O; Colpaert C; Dedeurwaerdere F; Dessauvagie B; Duwel V; Floris G; Fox S; Gerosa C; Hastir D; Jaffer S; Kurpershoek E; Lacroix-Triki M; Laka A; Lambein K; MacGrogan GM; Marchiò C; Martin Martinez MD; Nofech-Mozes S; Peeters D; Ravarino A; Reisenbichler E; Resetkova E; Sanati S; Schelfhout AM; Schelfhout V; Shaaban A; Sinke R; Stanciu-Pop CM; van Deurzen CHM; Van de Vijver KK; Van Rompuy AS; Vincent-Salomon A; Wen HY; Wong S; Bouzin C; Galant C
Mod Pathol; 2021 Dec; 34(12):2130-2140. PubMed ID: 34218258
[TBL] [Abstract][Full Text] [Related]
4. Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group.
Swisher SK; Wu Y; Castaneda CA; Lyons GR; Yang F; Tapia C; Wang X; Casavilca SA; Bassett R; Castillo M; Sahin A; Mittendorf EA
Ann Surg Oncol; 2016 Jul; 23(7):2242-8. PubMed ID: 26965699
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers.
Tian T; Ruan M; Yang W; Shui R
Oncotarget; 2016 Jul; 7(28):44395-44405. PubMed ID: 27323808
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers treated with neoadjuvant chemotherapy.
Yang X; Rao J; Yang W; Shui R
Target Oncol; 2018 Dec; 13(6):757-767. PubMed ID: 30406444
[TBL] [Abstract][Full Text] [Related]
7. ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations.
Cserni B; Kilmartin D; O'Loughlin M; Andreu X; Bagó-Horváth Z; Bianchi S; Chmielik E; Figueiredo P; Floris G; Foschini MP; Kovács A; Heikkilä P; Kulka J; Laenkholm AV; Liepniece-Karele I; Marchiò C; Provenzano E; Regitnig P; Reiner A; Ryška A; Sapino A; Stovgaard ES; Quinn C; Zolota V; Webber M; Glynn SA; Bori R; Csörgő E; Oláh-Németh O; Pancsa T; Sejben A; Sejben I; Vörös A; Zombori T; Nyári T; Callagy G; Cserni G
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831541
[TBL] [Abstract][Full Text] [Related]
8. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.
Matsumoto H; Thike AA; Li H; Yeong J; Koo SL; Dent RA; Tan PH; Iqbal J
Breast Cancer Res Treat; 2016 Apr; 156(2):237-47. PubMed ID: 26960711
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers.
Ruan M; Tian T; Rao J; Xu X; Yu B; Yang W; Shui R
Diagn Pathol; 2018 Aug; 13(1):66. PubMed ID: 30170605
[TBL] [Abstract][Full Text] [Related]
10. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
Kos Z; Roblin E; Kim RS; Michiels S; Gallas BD; Chen W; van de Vijver KK; Goel S; Adams S; Demaria S; Viale G; Nielsen TO; Badve SS; Symmans WF; Sotiriou C; Rimm DL; Hewitt S; Denkert C; Loibl S; Luen SJ; Bartlett JMS; Savas P; Pruneri G; Dillon DA; Cheang MCU; Tutt A; Hall JA; Kok M; Horlings HM; Madabhushi A; van der Laak J; Ciompi F; Laenkholm AV; Bellolio E; Gruosso T; Fox SB; Araya JC; Floris G; Hudeček J; Voorwerk L; Beck AH; Kerner J; Larsimont D; Declercq S; Van den Eynden G; Pusztai L; Ehinger A; Yang W; AbdulJabbar K; Yuan Y; Singh R; Hiley C; Bakir MA; Lazar AJ; Naber S; Wienert S; Castillo M; Curigliano G; Dieci MV; André F; Swanton C; Reis-Filho J; Sparano J; Balslev E; Chen IC; Stovgaard EIS; Pogue-Geile K; Blenman KRM; Penault-Llorca F; Schnitt S; Lakhani SR; Vincent-Salomon A; Rojo F; Braybrooke JP; Hanna MG; Soler-Monsó MT; Bethmann D; Castaneda CA; Willard-Gallo K; Sharma A; Lien HC; Fineberg S; Thagaard J; Comerma L; Gonzalez-Ericsson P; Brogi E; Loi S; Saltz J; Klaushen F; Cooper L; Amgad M; Moore DA; Salgado R;
NPJ Breast Cancer; 2020; 6():17. PubMed ID: 32411819
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Roles of Neutrophil-to-Lymphocyte Ratio and Stromal Tumor-Infiltrating Lymphocytes and Their Relationship in Locally Advanced Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.
Dong X; Liu C; Yuan J; Wang S; Ding N; Li Y; Wu Y; Xiao Z
Breast Care (Basel); 2021 Aug; 16(4):328-334. PubMed ID: 34602938
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers.
Loi S; Drubay D; Adams S; Pruneri G; Francis PA; Lacroix-Triki M; Joensuu H; Dieci MV; Badve S; Demaria S; Gray R; Munzone E; Lemonnier J; Sotiriou C; Piccart MJ; Kellokumpu-Lehtinen PL; Vingiani A; Gray K; Andre F; Denkert C; Salgado R; Michiels S
J Clin Oncol; 2019 Mar; 37(7):559-569. PubMed ID: 30650045
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy.
de Jong VMT; Wang Y; Ter Hoeve ND; Opdam M; Stathonikos N; Jóźwiak K; Hauptmann M; Cornelissen S; Vreuls W; Rosenberg EH; Koop EA; Varga Z; van Deurzen CHM; Mooyaart AL; Córdoba A; Groen EJ; Bart J; Willems SM; Zolota V; Wesseling J; Sapino A; Chmielik E; Ryska A; Broeks A; Voogd AC; Loi S; Michiels S; Sonke GS; van der Wall E; Siesling S; van Diest PJ; Schmidt MK; Kok M; Dackus GMHE; Salgado R; Linn SC
J Clin Oncol; 2022 Jul; 40(21):2361-2374. PubMed ID: 35353548
[TBL] [Abstract][Full Text] [Related]
14. Stromal Tumor Infiltrating Lymphocytes (sTILs) Were Associated with a Higher Grade and a Lower Stage of Indonesian Triple Negative Breast Cancers.
Widodo I; Ghozali A; Purwanto I; Ferronika P
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2749-2754. PubMed ID: 36037130
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer.
Sønderstrup IMH; Jensen MB; Ejlertsen B; Eriksen JO; Gerdes AM; Kruse TA; Larsen MJ; Thomassen M; Laenkholm AV
Acta Oncol; 2019 Mar; 58(3):363-370. PubMed ID: 30614364
[TBL] [Abstract][Full Text] [Related]
16. Artificial intelligence-based digital scores of stromal tumour-infiltrating lymphocytes and tumour-associated stroma predict disease-specific survival in triple-negative breast cancer.
Albusayli R; Graham JD; Pathmanathan N; Shaban M; Raza SEA; Minhas F; Armes JE; Rajpoot N
J Pathol; 2023 May; 260(1):32-42. PubMed ID: 36705810
[TBL] [Abstract][Full Text] [Related]
17. Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer.
Perez EA; Ballman KV; Tenner KS; Thompson EA; Badve SS; Bailey H; Baehner FL
JAMA Oncol; 2016 Jan; 2(1):56-64. PubMed ID: 26469139
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer.
Abuhadra N; Sun R; Litton JK; Rauch GM; Yam C; Chang JT; Seth S; Bassett R; Lim B; Thompson AM; Mittendorf E; Adrada BE; Damodaran S; White J; Ravenberg E; Candelaria R; Arun B; Ueno NT; Santiago L; Saleem S; Abouharb S; Murthy RK; Ibrahim N; Sahin AA; Valero V; Symmans WF; Tripathy D; Moulder S; Huo L
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267631
[TBL] [Abstract][Full Text] [Related]
19. Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
Hudeček J; Voorwerk L; van Seijen M; Nederlof I; de Maaker M; van den Berg J; van de Vijver KK; Sikorska K; Adams S; Demaria S; Viale G; Nielsen TO; Badve SS; Michiels S; Symmans WF; Sotiriou C; Rimm DL; Hewitt SM; Denkert C; Loibl S; Loi S; Bartlett JMS; Pruneri G; Dillon DA; Cheang MCU; Tutt A; Hall JA; Kos Z; Salgado R; Kok M; Horlings HM;
NPJ Breast Cancer; 2020; 6():15. PubMed ID: 32436923
[TBL] [Abstract][Full Text] [Related]
20. Association of androgen receptor and tumour-infiltrating lymphocytes with bone recurrence in triple-negative breast cancer.
Ilenič P; Herman A; Langerholc E; Gazić B; Šeruga B
J Bone Oncol; 2024 Feb; 44():100518. PubMed ID: 38374890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
